Related references
Note: Only part of the references are listed.The Role of Sclerostin in Bone Diseases
Elias S. Vasiliadis et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Uncarboxylated osteocalcin promotes proliferation and metastasis of MDA-MB-231 cells through TGF-beta/SMAD3 signaling pathway
Jiaojiao Xu et al.
BMC MOLECULAR AND CELL BIOLOGY (2022)
Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer
Matthew Abramson et al.
CLINICAL NEPHROLOGY (2021)
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
Konstantinos Venetis et al.
CELLS (2021)
Endocrine role of bone in the regulation of energy metabolism
Ruoyu Zhou et al.
BONE RESEARCH (2021)
Emerging Players in Prostate Cancer-Bone Niche Communication
Giulia Furesi et al.
TRENDS IN CANCER (2021)
New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence
Ko-Hsiu Lu et al.
CANCER AND METASTASIS REVIEWS (2020)
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments
Navid Sobhani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Osteocalcin promotes bone mineralization but is not a hormone
Stavros C. Manolagas
PLOS GENETICS (2020)
Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer
Ginette S. Santiago-Sanchez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Bone, a Secondary Growth Site of Breast and Prostate Carcinomas: Role of Osteocytes
Paola Maroni et al.
CANCERS (2020)
Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes
Heike Weidner et al.
JCI INSIGHT (2020)
Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle
Toshihisa Komori
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology
Xuzhu Lin et al.
MOLECULAR METABOLISM (2020)
Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
Andre Mansinho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism
Soohyun P. Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Prostate Cancer and Bone Metastases: The Underlying Mechanisms
Sok Kuan Wong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
Wen Liu et al.
OPEN BIOLOGY (2019)
CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
Yongning Lu et al.
CELL COMMUNICATION AND SIGNALING (2019)
The Endocrine Function of Osteocalcin Regulated by Bone Resorption: A Lesson from Reduced and Increased Bone Mass Diseases
Michela Rossi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Osteocalcin-GPRC6A: An update of its clinical and biological multi-organic interactions
Martha Cristina Diaz-Franco et al.
MOLECULAR MEDICINE REPORTS (2019)
Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature
Constantinos Savva et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2019)
Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis
Changki Lee et al.
CANCER LETTERS (2018)
Plasma FGF23 is not elevated in prostate cancer
Mariska C. Vlot et al.
CLINICA CHIMICA ACTA (2018)
Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor (TGF) signaling
Terese Karlsson et al.
PROSTATE (2018)
Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
Alison B. Shupp et al.
CANCERS (2018)
Loss of the adipokine lipocalin-2 impairs satellite cell activation and skeletal muscle regeneration
Irena A. Rebalka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
Lipocalin 2: a potential therapeutic target for breast cancer metastasis
Chenxia Hu et al.
ONCOTARGETS AND THERAPY (2018)
Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer
Saba Choudhary et al.
SCIENTIFIC REPORTS (2018)
Klotho expression in long bones regulates FGF23 production during renal failure
Jovana Kaludjerovic et al.
FASEB JOURNAL (2017)
Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts
Masanori Koide et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model
Ruisong Ye et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Klotho expression in osteocytes regulates bone metabolism and controls bone formation
Hirotaka Komaba et al.
KIDNEY INTERNATIONAL (2017)
Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth
J. Delgado-Calle et al.
LEUKEMIA (2017)
MC4R-dependent suppression of appetite by bone-derived lipocalin 2
Ioanna Mosialou et al.
NATURE (2017)
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils
Camilla Engblom et al.
SCIENCE (2017)
Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions
Kelly Aukes et al.
PLOS ONE (2017)
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma
Michelle M. McDonald et al.
BLOOD (2017)
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment
Sobeyda B. Gomez-Chou et al.
CANCER RESEARCH (2017)
Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression
Changjun Li et al.
MARROW (2016)
New insights into the biology of osteocalcin
Meredith L. Zoch et al.
BONE (2016)
Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise
Paula Mera et al.
CELL METABOLISM (2016)
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
Homare Eda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2
Dewei Ye et al.
JOURNAL OF HEPATOLOGY (2016)
The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases
Vanessa Abella et al.
BIOMARKERS (2015)
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis
Nadia Rucci et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
SOST Inhibits Prostate Cancer Invasion
Bryan D. Hudson et al.
PLOS ONE (2015)
The PTH-Vitamin D-FGF23 axis
Jenny E. Blau et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2015)
FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells
Attaya Suvannasankha et al.
ONCOTARGET (2015)
A Review of Osteocyte Function and the Emerging Importance of Sclerostin
Jocelyn T. Compton et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2014)
Bone marrow plasma macrophage inflammatory protein protein-1 alpha(MIP-1 alpha) and sclerostin in multiple myeloma: Relationship with bone disease and clinical characteristics
Xiao-Tao Wang et al.
LEUKEMIA RESEARCH (2014)
FGF23: Mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?
Esther K. Lee et al.
MEDICAL HYPOTHESES (2014)
Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids
B. Garcia-Fontana et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Oncogenic osteomalacia - Hypophosphataemic spectrum from benignancy to malignancy
P. Chiam et al.
BONE (2013)
Maternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions
Franck Oury et al.
CELL (2013)
Altered Bone Development and Turnover in Transgenic Mice Over-Expressing Lipocalin-2 in Bone
Delfina Costa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Osteocalcin Induces Release of Glucagon-Like Peptide-1 and Thereby Stimulates Insulin Secretion in Mice
Akiko Mizokami et al.
PLOS ONE (2013)
Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover
Maria P. Yavropoulou et al.
BONE (2012)
Lipocalin-2 ameliorates granulocyte functionality
Andrea Schroll et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy
Evangelos Terpos et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
GPRC6A regulates prostate cancer progression
Min Pi et al.
PROSTATE (2012)
Endocrine Regulation of Male Fertility by the Skeleton
Franck Oury et al.
CELL (2011)
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBF beta-dependent expression of the Wnt antagonist, sclerostin
Daniel Mendoza-Villanueva et al.
BREAST CANCER RESEARCH (2011)
Osteoblasts Are a Major Source of inflammatory Cytokines in the Tumor Microenvironment of Bone Metastatic Breast Cancer
Karen M. Bussard et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis
Thorsten Berger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serum Undercarboxylated Osteocalcin as Biomarker of Vitamin K intake and Risk of Prostate Cancer: A Nested Case-Control Study in the Heidelberg Cohort of the European Prospective Investigation into Cancer and Nutrition
Katharina Nimptsch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Differential expression of osteocalcin during the metastatic progression of prostate cancer
Thomas A. Gardner et al.
ONCOLOGY REPORTS (2009)
Lipocalin 2 promotes breast cancer progression
Jiang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1
Jyothsna Gattineni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia
N. Moniaux et al.
BRITISH JOURNAL OF CANCER (2008)
The prognostic significance of BMP-6 signaling in prostate cancer
Hiu-Fung Yuen et al.
MODERN PATHOLOGY (2008)
The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells
Alessio Lannetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer
Maret Bauer et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
The bone microenvironment in metastasis; what is special about bone?
Karen M. Bussard et al.
CANCER AND METASTASIS REVIEWS (2008)
BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion
Hany Kayed et al.
MOLECULAR CANCER (2007)
Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia
Casey L. Cotant et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Predictive value of osteocalcin and β-CrossLaps in metastatic breast cancer
Ahmed M. Salem et al.
CLINICAL BIOCHEMISTRY (2007)
The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance
Qing-Wu Yan et al.
DIABETES (2007)
Role of Wnts in prostate cancer bone metastases
CL Hall et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Management of bone metastases in cancer: A review
G Selvaggi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo
YX Sun et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin
J Mishra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone
ET Keller et al.
CANCER AND METASTASIS REVIEWS (2001)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)